Search results
Enrolling in Medicare when laid off
The Salem News· 5 days agoDon...
Fixing Social Security: Options for a Sustainable Future
TheStreet.com· 11 hours agoLearn how a tax credit option could benefit both Social Security and high-income Medicare...
Cigna lifts annual profit forecast
Reuters· 10 hours ago, opens new tab raised its annual profit forecast on Thursday, helped by lower-than-expected medical costs and strength in its pharmacy benefit...
Wegovy sales more than doubled as the weight loss drug boom keeps powering Novo Nordisk
Quartz· 15 hours agoSales of the Danish pharma giant's obesity drugs grew 25% year over year in this year's first...
CVS stock plunges after earnings numbers one analyst 'did not even believe'
Yahoo Finance· 1 day agoShe added the company is confident in its ability to address theMedicare Advantage challenges, and...
CVS Health Corp (CVS) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
GuruFocus.com via Yahoo Finance· 20 hours agoYou're in probably the right ZIP code as you think about what the margin is on the -- or implied margin is on the Medicare business. Q: Can you talk about the scaling dynamics ...
Enrollment rising for Medicare savings programs
The Eagle-Tribune· 6 days agoThe number of senior citizens on the state’s Medicare savings programs has increased since eligibility was expanded to help more beneficiaries pay for health care premiums ...
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B | JD Supra
JD Supra· 7 days agoOn April 15, the Centers for Medicare & Medicaid Services (CMS) released a fact sheet on the potential national coverage determination (NCD) for pre-exposure prophylaxis ( ...
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
San Francisco Chronicle· 1 day agoCVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below...
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
AOL· 13 hours agoNovo Nordisk (NVO) stock was trading down Thursday despite strong first quarter results, beating Wall Street consensus, led by the blockbuster GLP-1s Ozempic for diabetes and Wegovy for weight ...
